Notice of AGM


AstraZeneca PLC (the Company) announced today the publication of its Notice of Annual General Meeting 2015 and Shareholders' Circular; a covering letter from the Chairman; and 'AstraZeneca 2014 In Brief'.

Copies of the documents have been submitted to the National Storage Mechanism and will shortly be available for inspection at The documents are also available on the Company's website at

The Company's Annual Report and Form 20-F Information 2014 was published on 10 March 2015.

The above documents are being despatched to shareholders today.

The meeting place for the Annual General Meeting (AGM) will be the Lancaster London Hotel, Lancaster Terrace, London, W2 2TY and the AGM will commence at 2.30 pm (BST) on 24 April 2015.

A C N Kemp

Company Secretary

19 March 2015

About Us

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. For more information please visit:


Documents & Links